IRIS - Res&Arch Institutional Research Information System - Research & Archive

GROTTELLI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.387
AS - Asia 1.100
EU - Europa 834
SA - Sud America 237
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 29
Totale 3.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.342
SG - Singapore 531
BR - Brasile 191
IE - Irlanda 178
IT - Italia 166
CN - Cina 137
VN - Vietnam 133
HK - Hong Kong 124
RU - Federazione Russa 101
UA - Ucraina 88
DE - Germania 70
FR - Francia 55
FI - Finlandia 52
KR - Corea 44
GB - Regno Unito 29
RO - Romania 22
BD - Bangladesh 21
IN - India 19
TR - Turchia 18
CA - Canada 17
AR - Argentina 15
NL - Olanda 14
BE - Belgio 13
MX - Messico 13
JP - Giappone 10
PK - Pakistan 10
IQ - Iraq 9
ZA - Sudafrica 9
AT - Austria 7
PL - Polonia 7
CO - Colombia 6
SE - Svezia 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
LT - Lituania 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
CH - Svizzera 4
CL - Cile 4
CR - Costa Rica 4
EU - Europa 4
ID - Indonesia 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ES - Italia 3
JM - Giamaica 3
MA - Marocco 3
MY - Malesia 3
BO - Bolivia 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
NG - Nigeria 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
NI - Nicaragua 1
OM - Oman 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 3.591
Salva come PNG Salva come JPEG
Città #
Singapore 400
Chandler 196
Dublin 178
San Jose 143
Hong Kong 122
Ashburn 85
Perugia 81
San Mateo 64
Dong Ket 59
Santa Clara 56
Boardman 50
Jacksonville 47
Moscow 43
Seoul 43
Beijing 36
Lauterbourg 32
Ann Arbor 31
Medford 31
Princeton 31
Munich 30
Ho Chi Minh City 27
Altamura 26
The Dalles 26
Wilmington 24
Lawrence 23
São Paulo 23
New York 22
Bucharest 20
Turku 20
Andover 18
Falls Church 18
Dallas 17
Hanoi 17
Los Angeles 15
Piscataway 13
Brussels 12
Fremont 12
Council Bluffs 11
Amsterdam 10
Helsinki 10
Chennai 9
Des Moines 8
Phoenix 8
Tokyo 8
Baghdad 7
Brooklyn 7
Chicago 7
Frankfurt am Main 7
Johannesburg 7
Nuremberg 7
Rio de Janeiro 7
Curitiba 6
Izmir 6
London 6
Montreal 6
Norwalk 6
Orem 6
Redmond 6
Columbus 5
Da Nang 5
Redwood City 5
Saint Petersburg 5
San Francisco 5
San Paolo di Civitate 5
Vicenza 5
Vienna 5
Warsaw 5
Ankara 4
Atlanta 4
Brno 4
Dearborn 4
Falkenstein 4
Houston 4
Montefalco 4
Poplar 4
Belo Horizonte 3
Boston 3
Brasília 3
Brescia 3
Buffalo 3
Campinas 3
Campobasso 3
Can Tho 3
Caracas 3
City of London 3
Concord 3
Dammam 3
Denver 3
Fortaleza 3
Frankfurt Am Main 3
Harbin 3
Jinan 3
Kingston 3
Memphis 3
Milan 3
Philadelphia 3
Rabat 3
Secaucus 3
Shanghai 3
São Carlos 3
Totale 2.398
Salva come PNG Salva come JPEG
Nome #
ALPHA-TOCOPHEROL SUCCINATE INHIBITS NF-KAPPA-B NUCLEAR TRANSLOCATION VIA NRF2 ACTIVATION THUS INDUCING A DETOXIFICATION RESPONSE AGAINST PRO-OXIDANT REDOX-CYCLING COMPOUNDS 146
Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells 146
Denervation does not Induce Muscle Atrophy Through Oxidative Stress 138
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-κB and Nrf2 signalling. 128
Adenosine A1 receptors contribute to mitochondrial vulnerability to pro-oxidant stressors 126
Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells 118
2-Cl-adenosine: an antimetabolite in human prostate cancer PC3 cells. 116
Cyclo (His-Pro) Protects SOD1G93A Microglial Cells from Paraquat Induced Toxicity 114
Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity 113
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up regulation of antioxidant defence. 112
Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation 112
Focus on cyclo(His-Pro): history and perspectives as antioxidant peptide. 111
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 111
A(1) and A(3) adenosine receptors alter glutathione status in an organ-specific manner and influence the changes after inhibition of gamma-glutamylcysteine ligase. 110
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells. 99
Potential influence of cyclo(His-pro) on proteostasis: Impact on neurodegenerative diseases 99
Molecular and Cellular Studies Reveal Folding Defects of Human Ornithine Aminotransferase Variants Associated With Gyrate Atrophy of the Choroid and Retina 94
Dimerization drives proper folding of human alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 92
Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach 90
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase 90
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence 89
Peroxynitrite Activates the NLRP3 Inflammasome Cascade in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis 88
CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1 84
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 83
Cyclo(His-Pro) alleviates LPS-induced neuroinflammation 81
Molecular Dynamics-Ensemble Docking and Biophysical Studies for Structure-Based Identification of Non-Amino Acidic Ligands of DDAH-1 80
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 80
ROS-independent Nrf2 activation in prostate cancer 79
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 77
The role of cyclo(His-Pro) in neurodegeneration 77
Impact of Enniatin and Deoxynivalenol Co-Occurrence on Plant, Microbial, Insect, Animal and Human Systems: Current Knowledge and Future Perspectives 74
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 73
Molecular events underlying antioxidant properties of cyclo(His-Pro) in PC12 cells 71
Commensal fungi and oxalate degradation: is there a link? 69
Erratum: Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signaling (Journal of Neurochemistry (2009) 111 (956-966)) 68
MITOCHONDRIAL EXPRESSION OF A1 ADENOSINE RECEPTOR EXACERBATES PRO-OXIDANT INJURY 68
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 67
Up-regulation of antioxidant defence by cyclo(His-Pro) through Nrf2 activation 59
Phosphoproteomic analysis of the effect of cyclo-(His-Pro)dipeptide on PC12 cells 54
Towards modeling enteric hyperoxaluria in a tripartite microbiota-gut-kidney microphysiological system 14
Nanobodies as therapies for loss-of-function misfolding diseases: the example of Primary Hyperoxaluria Type 1 14
Totale 3.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022286 0 39 6 3 14 8 9 83 19 28 33 44
2022/2023581 32 101 9 45 55 58 0 25 220 5 22 9
2023/2024250 22 23 12 3 1 1 44 10 24 7 48 55
2024/2025631 15 49 26 28 80 44 33 64 110 31 89 62
2025/20261.433 97 92 90 214 194 142 236 56 147 110 44 11
2026/202766 33 33 0 0 0 0 0 0 0 0 0 0
Totale 3.714